Holen Sie sich die Stockscreener-App
38.67
1.55%
0.59
Vorhandelsmarkt:
38.44
-0.23
-0.59%
Schlusskurs vom Vortag:
$38.08
Offen:
$37.89
24-Stunden-Volumen:
8.41M
Relative Volume:
0.79
Marktkapitalisierung:
$19.01B
Einnahmen:
$178.19B
Nettoeinkommen (Verlust:
$2.05B
KGV:
9.5607
EPS:
4.0447
Netto-Cashflow:
$1.08B
1W Leistung:
-0.36%
1M Leistung:
+12.91%
6M Leistung:
-30.34%
1J Leistung:
-31.81%
1-Tages-Spanne:
$37.25
$38.84
1-Wochen-Bereich:
$37.25
$39.00
52-Wochen-Spanne:
$25.07
$66.81
Centene Corp Stock (CNC) Company Profile
Firmenname
Centene Corp
Sektor
Branche
Telefon
(314) 725-4477
Adresse
7700 FORSYTH BLVD., ST LOUIS
Vergleichen Sie CNC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNC
Centene Corp
|
38.67 | 18.72B | 178.19B | 2.05B | 1.08B | 4.0447 |
|
UNH
Unitedhealth Group Inc
|
328.37 | 293.13B | 435.16B | 18.37B | 17.37B | 19.16 |
|
CVS
Cvs Health Corp
|
78.97 | 99.32B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
ELV
Elevance Health Inc
|
341.04 | 73.30B | 194.82B | 5.53B | 3.77B | 24.45 |
|
CI
Cigna Group
|
262.60 | 70.18B | 268.22B | 6.55B | 7.44B | 22.67 |
|
HUM
Humana Inc
|
256.66 | 30.12B | 123.11B | 1.58B | 2.44B | 13.03 |
Centene Corp Stock (CNC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-14 | Eingeleitet | Goldman | Sell |
| 2025-07-28 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-07-23 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-07-21 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-07-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-07-10 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-07-02 | Herabstufung | UBS | Buy → Neutral |
| 2025-06-09 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-06-02 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-04-08 | Hochstufung | Jefferies | Underperform → Hold |
| 2025-02-06 | Herabstufung | Argus | Buy → Hold |
| 2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-12-13 | Hochstufung | UBS | Neutral → Buy |
| 2024-12-10 | Herabstufung | Jefferies | Hold → Underperform |
| 2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-03-21 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-01-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-09-05 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-06-20 | Eingeleitet | UBS | Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-03-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-02-23 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-12-13 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-09-30 | Eingeleitet | Argus | Buy |
| 2022-08-26 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-07-28 | Fortgesetzt | Barclays | Overweight |
| 2022-07-14 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-21 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Fortgesetzt | Bernstein | Outperform |
| 2022-05-26 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-01-07 | Fortgesetzt | Barclays | Overweight |
| 2022-01-06 | Fortgesetzt | JP Morgan | Overweight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-12-13 | Bestätigt | BMO Capital Markets | Outperform |
| 2021-12-13 | Bestätigt | BofA Securities | Buy |
| 2021-12-13 | Bestätigt | Credit Suisse | Neutral |
| 2021-12-13 | Bestätigt | Mizuho | Neutral |
| 2021-12-13 | Bestätigt | Oppenheimer | Outperform |
| 2021-12-13 | Bestätigt | Stephens | Overweight |
| 2021-12-13 | Bestätigt | Truist | Buy |
| 2021-12-13 | Bestätigt | Wells Fargo | Overweight |
| 2021-12-13 | Bestätigt | Wolfe Research | Outperform |
| 2021-11-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-05-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-03-10 | Eingeleitet | Mizuho | Neutral |
| 2021-01-21 | Fortgesetzt | Goldman | Neutral |
| 2021-01-15 | Herabstufung | Jefferies | Buy → Hold |
| 2020-09-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-02-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-02-03 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-01-28 | Bestätigt | Bernstein | Outperform |
| 2020-01-06 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-05-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-10-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-07-18 | Fortgesetzt | Citigroup | Neutral |
| 2017-12-18 | Bestätigt | Jefferies | Buy |
| 2017-09-13 | Bestätigt | Leerink Partners | Mkt Perform |
| 2017-06-07 | Eingeleitet | Morgan Stanley | Overweight |
| 2017-05-22 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-04-05 | Eingeleitet | Deutsche Bank | Buy |
| 2017-03-23 | Herabstufung | Citigroup | Buy → Neutral |
| 2017-02-08 | Bestätigt | Barclays | Overweight |
| 2017-02-07 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-01-04 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Centene Corp Aktie (CNC) Neueste Nachrichten
Should You Hold Centene (CNC)? - Yahoo Finance
CNC Stock Price Prediction 2026, 2027 & 2030: Analyst Targets & Quantum Computing Outlook - Benzinga
Sarah London: 100 Most Influential People in Healthcare 2025 - Modern Healthcare
Centene Corporation $CNC Shares Acquired by Amundi - MarketBeat
Centene director Burdick sells $2.57 million in stock - Investing.com India
CENTENE CORP Director Kenneth A Burdick Sells Shares - TradingView
Dir Burdick Sells 66,007 ($2.6M) Of Centene Corp [CNC] - TradingView
Why Analysts See Centene’s Story Shifting Amid Margin Recovery Hopes and Medicaid Risks - Yahoo Finance
Cresset Asset Management LLC Reduces Stock Holdings in Centene Corporation $CNC - MarketBeat
Will Centene Corporation stock benefit from upcoming earnings reportsQuarterly Growth Report & Real-Time Market Sentiment Reports - Newser
Guidance Cut From Higher Exchange Costs Could Be A Game Changer For Centene (CNC) - simplywall.st
Centene Corporation (CNC): A Bull Case Theory - Yahoo Finance
Is Centene Stock Underperforming the S&P 500? - Barchart.com
Invesco Ltd. Purchases 633,946 Shares of Centene Corporation $CNC - MarketBeat
Here’s Why Centene Corporation (CNC) Reduced Its Earnings Outlook - MSN
Sio Capital Management LLC Takes Position in Centene Corporation $CNC - MarketBeat
Centene (CNC): Assessing Valuation After a 10% 1-Month and 29% 3-Month Share Price Rebound - Yahoo Finance
Meridian Health Plan of Illinois Commits $1.15 Million to Expand St. Louis Area Foodbank Mobile Pantry Program - ADVFN
How buyback programs support Centene Corporation (QEN) stockMarket Sentiment Review & Verified Technical Trade Signals - Newser
Is Centene Corporation (QEN) stock worth buying before Fed actionPrice Action & Safe Investment Capital Preservation Plans - Newser
Centene Corp. stock underperforms Monday when compared to competitors - MSN
Korea Investment CORP Cuts Position in Centene Corporation $CNC - MarketBeat
Quadrature Capital Ltd Raises Stock Holdings in Centene Corporation $CNC - MarketBeat
Groupama Asset Managment Acquires 9,965 Shares of Centene Corporation $CNC - MarketBeat
Norges Bank Acquires Shares of 26,455,361 Centene Corporation $CNC - MarketBeat
Forget CVS, Buy This Healthcare Stock Instead - Finviz
Forget CVS, Buy This Healthcare Stock Instead - The Motley Fool
Centene (CNC) Up 12.7% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Boston Partners Acquires 38,595 Shares of Centene Corporation $CNC - MarketBeat
Why Centene (CNC) Is Up 9.8% After Trump’s Proposed ACA Subsidy Extension and What’s Next - Yahoo Finance
Inceptionr LLC Boosts Stock Position in Centene Corporation $CNC - MarketBeat
Can Centene Corporation stock hit analyst price targetsMarket Activity Report & Free High Return Stock Watch Alerts - BỘ NỘI VỤ
Recent SNAP Disruptions Highlight Urgent Need for Sustained Action Against Food Insecurity - Finviz
CMS Unveils 2027 Rule To Refocus Medicare Advantage On Outcomes - Benzinga
Jefferies Financial Group Inc. Has $4.88 Million Holdings in Centene Corporation $CNC - MarketBeat
Centene Corp. stock outperforms competitors on strong trading day - MarketWatch
Bill Nygren's Strategic Moves: Centene Corp Exits with a -2.14% Impact - GuruFocus
Centene Corporation $CNC Shares Sold by Rhumbline Advisers - MarketBeat
Centene Corp. Stock Climbs 4.6%, Outperforms Peers - 富途牛牛
Oscar, Centene, Humana Stocks Fall After-Hours As Trump Pushes Back On Obamacare Subsidy Extension — Retail Warns Of ‘Political Suicide’ - Stocktwits
Which are the top Quant picks among health insurers amid ACA uncertainty? - Seeking Alpha
Centene (CNC) and Molina Healthcare (MOH) Surge on New Health Pl - GuruFocus
PacBio, Bristol-Myers Squibb, Oscar Health, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know - Yahoo Finance
Centene lists former Clayton headquarters land for sale - STLtoday.com
Why Centene Stock Just Popped - Finviz
Centene puts two Clayton properties from scrapped $775M headquarters expansion up for sale - KSDK
S&P 500 Futures Climb in Premarket Trading; Centene, Millicom Intl Cellular Lead - Barron's
Stevens Capital Management LP Acquires 12,671 Shares of Centene Corporation $CNC - MarketBeat
Bernstein Raises Centene (CNC) Price Target to $45, Maintains Ou - GuruFocus
Bernstein raises Centene stock price target to $45 on Marketplace margin recovery - Investing.com
AcariaHealth Highlights National Biosimilars Education Efforts with Three Events – Company Announcement - Financial Times
Finanzdaten der Centene Corp-Aktie (CNC)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.32%
8.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):